Rocky Mountain Spotted Fever Alert: Northern Mexico Border Region

Rocky Mountain Spotted Fever in Northern Mexico

Situation Overview

The CDC has issued a Level 1 notice regarding Rocky Mountain spotted fever (RMSF) cases and associated deaths in northern Mexico's border region. Confirmed cases have been reported in:

  • Baja California
  • Sonora
  • Chihuahua
  • Coahuila
  • Nuevo León

Disease Background

RMSF is a bacterial infection transmitted through tick bites, caused by Rickettsia rickettsii. The disease is endemic to the Americas and historically associated with the Rocky Mountain region, though it occurs across North and South America. Illness onset typically occurs 2–14 days after tick exposure.

Symptoms and Clinical Presentation

Common manifestations include:

  • Fever, headache, and muscle aches
  • Rash (often appearing 3–5 days after fever onset)
  • Gastrointestinal symptoms
  • Severe cases may progress to organ dysfunction and death if untreated

Traveler Recommendations

Tick Prevention (Primary Measure):

  • Wear light-colored, long-sleeved clothing and pants tucked into socks in tick-prone areas
  • Apply EPA-registered insect repellents containing DEET, picaridin, or permethrin to exposed skin and clothing
  • Perform thorough tick checks after outdoor activities, including hidden areas (hairline, behind ears, groin)
  • Remove ticks promptly using tweezers; avoid folk remedies

Healthcare Access:

  • U.S. citizens traveling to affected regions should have travel health insurance that covers medical evacuation
  • Locate reliable medical facilities beforehand; many rural border areas have limited resources
  • Report fever, rash, or unexplained illness to healthcare providers immediately upon return home

Post-Travel Considerations

Travelers returning from affected areas who develop fever, headache, or rash within 2–14 days should seek medical evaluation and inform providers of tick exposure history and travel location.

Pharmacist's Note: RMSF requires early antimicrobial therapy for optimal outcomes—diagnosis and treatment should not be delayed awaiting confirmatory testing. While no vaccine exists, prevention through tick avoidance and proper removal techniques remains highly effective. Travelers should not self-treat suspected RMSF; professional medical evaluation is essential. Over-the-counter medications address symptoms only and do not treat the underlying infection.

Information Source

This alert reflects CDC guidance and remains subject to updates as epidemiologic conditions evolve.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.